• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于多发性硬化症中睡眠障碍和癫痫障碍发生率和流行率的系统回顾。

A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis.

机构信息

Department of Internal Medicine, University of Manitoba, Winnipeg, Canada/Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada

Department of Internal Medicine, University of Manitoba, Winnipeg, Canada.

出版信息

Mult Scler. 2015 Mar;21(3):342-9. doi: 10.1177/1352458514564486. Epub 2014 Dec 22.

DOI:10.1177/1352458514564486
PMID:25533301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4429167/
Abstract

BACKGROUND

Several studies have suggested that comorbid neurologic disorders are more common than expected in multiple sclerosis (MS).

OBJECTIVE

To estimate the incidence and prevalence of comorbid seizure disorders and sleep disorders in persons with MS and to evaluate the quality of studies included.

METHODS

The PUBMED, EMBASE, Web of Knowledge, and SCOPUS databases, conference proceedings, and reference lists of retrieved articles were searched. Two reviewers independently screened abstracts to identify relevant articles, followed by full-text review of selected articles. We assessed included studies qualitatively and quantitatively (I² statistic), and conducted meta-analyses among population-based studies.

RESULTS

We reviewed 32 studies regarding seizure disorders. Among population-based studies the incidence of seizure disorders was 2.28% (95% CI: 1.11-3.44%), while the prevalence was 3.09% (95% CI: 2.01-4.16%). For sleep disorders we evaluated 18 studies; none were population-based. The prevalence ranged from 0-1.6% for narcolepsy, 14.4-57.5% for restless legs syndrome, 2.22-3.2% for REM behavior disorder, and 7.14-58.1% for obstructive sleep apnea.

CONCLUSION

This review suggests that seizure disorders and sleep disorders are common in MS, but highlights gaps in the epidemiological knowledge of these conditions in MS worldwide. Other than central-western Europe and North America, most regions are understudied.

摘要

背景

多项研究表明,多发性硬化症(MS)患者合并神经障碍的情况比预期更为常见。

目的

评估 MS 患者合并癫痫和睡眠障碍的发病率和患病率,并评估纳入研究的质量。

方法

检索 PUBMED、EMBASE、Web of Knowledge 和 SCOPUS 数据库、会议记录以及检索文章的参考文献列表。两位审查员独立筛选摘要以确定相关文章,然后对选定文章进行全文审查。我们对纳入的研究进行定性和定量评估(I² 统计量),并对基于人群的研究进行荟萃分析。

结果

我们回顾了 32 项关于癫痫的研究。在基于人群的研究中,癫痫的发病率为 2.28%(95%CI:1.11-3.44%),而患病率为 3.09%(95%CI:2.01-4.16%)。对于睡眠障碍,我们评估了 18 项研究;没有一项是基于人群的。嗜睡症的患病率范围为 0-1.6%,不宁腿综合征为 14.4-57.5%,快速眼动行为障碍为 2.22-3.2%,阻塞性睡眠呼吸暂停为 7.14-58.1%。

结论

本综述表明,癫痫和睡眠障碍在 MS 中很常见,但突显了全球范围内对这些疾病在 MS 中流行病学知识的不足。除了中-西欧和北美外,大多数地区的研究都不足。

相似文献

1
A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis.一项关于多发性硬化症中睡眠障碍和癫痫障碍发生率和流行率的系统回顾。
Mult Scler. 2015 Mar;21(3):342-9. doi: 10.1177/1352458514564486. Epub 2014 Dec 22.
2
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review.多发性硬化症中心境障碍的发病率和患病率:系统评价。
Mult Scler. 2015 Mar;21(3):305-17. doi: 10.1177/1352458514564487. Epub 2015 Jan 12.
3
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.对多发性硬化症合并症发病率和患病率的系统评价:概述。
Mult Scler. 2015 Mar;21(3):263-81. doi: 10.1177/1352458514564491. Epub 2015 Jan 26.
4
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.
5
A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis.一项关于多发性硬化症中心血管、脑血管和外周血管疾病的发病率和患病率的系统回顾。
Mult Scler. 2015 Mar;21(3):318-31. doi: 10.1177/1352458514564485. Epub 2014 Dec 22.
6
A systematic review of the incidence and prevalence of cancer in multiple sclerosis.对多发性硬化症中癌症发病率和流行率的系统评价。
Mult Scler. 2015 Mar;21(3):294-304. doi: 10.1177/1352458514564489. Epub 2014 Dec 22.
7
Treatments for seizures in catamenial (menstrual-related) epilepsy.月经性(与月经相关)癫痫发作的治疗。
Cochrane Database Syst Rev. 2021 Sep 16;9(9):CD013225. doi: 10.1002/14651858.CD013225.pub3.
8
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.卡马西平与苯妥英钠单药治疗癫痫:个体参与者数据回顾
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD001911. doi: 10.1002/14651858.CD001911.pub3.
9
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.抗癫痫药物单药治疗癫痫:一项个体参与者数据的网络荟萃分析。
Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD011412. doi: 10.1002/14651858.CD011412.pub4.
10
The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic review.多发性硬化症中并发胃肠道、肌肉骨骼、眼部、肺部和肾脏疾病的发病率和流行率:系统评价。
Mult Scler. 2015 Mar;21(3):332-41. doi: 10.1177/1352458514564488. Epub 2014 Dec 23.

引用本文的文献

1
Sleep and Risk of Multiple Sclerosis: Bridging the Gap Between Inflammation and Neurodegeneration via Glymphatic Failure.睡眠与多发性硬化症风险:通过类淋巴系统功能障碍弥合炎症与神经退行性变之间的差距
Brain Sci. 2025 Jul 19;15(7):766. doi: 10.3390/brainsci15070766.
2
Pediatric-Onset Multiple Sclerosis (POMS) and Epilepsy: Exploring Etiological Complexity-Outcomes from a Single-Center Experience.儿童期起病的多发性硬化症(POMS)与癫痫:探索病因复杂性——来自单中心经验的结果
Children (Basel). 2025 May 14;12(5):631. doi: 10.3390/children12050631.
3
Evaluation of Multiple Sclerosis Care and Its Impact on Brain Health: A United Arab Emirates Center Experience.

本文引用的文献

1
Neurological comorbidity and survival in multiple sclerosis.多发性硬化症中的神经合并症与生存率
Mult Scler Relat Disord. 2014 Jan;3(1):72-7. doi: 10.1016/j.msard.2013.06.006. Epub 2013 Jul 18.
2
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.对多发性硬化症合并症发病率和患病率的系统评价:概述。
Mult Scler. 2015 Mar;21(3):263-81. doi: 10.1177/1352458514564491. Epub 2015 Jan 26.
3
Impact of comorbidity on fatigue management intervention outcomes among people with multiple sclerosis: an exploratory investigation.
多发性硬化症护理评估及其对脑健康的影响:阿联酋某中心的经验
Cureus. 2025 Mar 25;17(3):e81201. doi: 10.7759/cureus.81201. eCollection 2025 Mar.
4
The neuropathobiology of multiple sclerosis.多发性硬化的神经病理学。
Nat Rev Neurosci. 2024 Jul;25(7):493-513. doi: 10.1038/s41583-024-00823-z. Epub 2024 May 24.
5
[Comorbidities in multiple sclerosis and their influence on the choice of treatment].[多发性硬化症的合并症及其对治疗选择的影响]
Rev Neurol. 2024 Mar 16;78(6):157-170. doi: 10.33588/rn.7806.2023277.
6
Factors affecting physical and mental fatigue in adults from South Korea: A cross-sectional study.影响韩国成年人身心疲劳的因素:一项横断面研究。
Medicine (Baltimore). 2023 Dec 15;102(50):e36549. doi: 10.1097/MD.0000000000036549.
7
Sleep-related breathing disorder (central sleep apnoea) improved coincidentally by medical therapy with fumarates (dimethyl fumarate).睡眠相关呼吸障碍(中枢性睡眠呼吸暂停)通过富马酸盐(富马酸二甲酯)药物治疗得到了同步改善。
Drugs Context. 2023 Nov 23;12. doi: 10.7573/dic.2023-6-3. eCollection 2023.
8
Sleep status in multiple sclerosis: Role of vitamin D and body mass index.多发性硬化症中的睡眠状况:维生素D和体重指数的作用。
Curr J Neurol. 2022 Apr 4;21(2):66-73. doi: 10.18502/cjn.v21i2.10489.
9
Epileptic seizures at multiple sclerosis onset and their role in disease progression.癫痫发作在多发性硬化症发病时的情况及其在疾病进展中的作用。
Ther Adv Neurol Disord. 2023 Oct 6;16:17562864231192826. doi: 10.1177/17562864231192826. eCollection 2023.
10
The case report of MOG and NMDAR IgG double positive encephalitis treated with subcutaneous ofatumumab.MOG 和 NMDAR IgG 双阳性脑炎经皮下奥法妥木单抗治疗的病例报告。
Front Immunol. 2023 Aug 15;14:1183488. doi: 10.3389/fimmu.2023.1183488. eCollection 2023.
合并症对多发性硬化症患者疲劳管理干预结果的影响:一项探索性调查。
Int J MS Care. 2013 Spring;15(1):21-6. doi: 10.7224/1537-2073.2012-011.
4
Association between multiple sclerosis and epilepsy: large population-based record-linkage studies.多发性硬化症与癫痫的关联:基于大型人群的记录链接研究。
BMC Neurol. 2013 Dec 4;13:189. doi: 10.1186/1471-2377-13-189.
5
Prevalence of epilepsy in a cohort of patients with multiple sclerosis.多发性硬化症患者队列中的癫痫患病率。
Seizure. 2014 Jan;23(1):81-3. doi: 10.1016/j.seizure.2013.09.008. Epub 2013 Sep 21.
6
Seizure characteristics in multiple sclerosis patients.多发性硬化症患者的癫痫发作特征。
J Res Med Sci. 2013 Mar;18(Suppl 1):S74-7.
7
Restless legs syndrome in Iranian multiple sclerosis patients: a case-control study.伊朗多发性硬化症患者的不宁腿综合征:一项病例对照研究。
Int J Prev Med. 2013 May;4(Suppl 2):S189-93.
8
Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures.早发型和晚发型多发性硬化症伴发癫痫患者的临床特征比较。
Acta Neurol Belg. 2013 Dec;113(4):421-6. doi: 10.1007/s13760-013-0210-x. Epub 2013 May 22.
9
Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event.脂质谱与干扰素-β治疗后首次脱髓鞘事件后 24 个月内患者的病变形成有关。
J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1186-91. doi: 10.1136/jnnp-2012-304740. Epub 2013 Apr 17.
10
Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis.多发性硬化症成人疼痛的患病率和自然病程:系统评价和荟萃分析。
Pain. 2013 May;154(5):632-642. doi: 10.1016/j.pain.2012.12.002. Epub 2012 Dec 14.